Skip to main content

Advertisement

SpringerLink
Log in

Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases

  • Review Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most common neurodegenerative disorders and exact a burden on our society greater than cardiovascular disease and cancer combined. While cognitive and motor symptoms are used to define AD and PD, respectively, patients with both disorders exhibit sleep disturbances including insomnia, hypersomnia and excessive daytime napping. The molecular basis of perturbed sleep in AD and PD may involve damage to hypothalamic and brainstem nuclei that control sleep–wake cycles. Perturbations in neurotransmitter and hormone signaling (e.g., serotonin, norepinephrine and melatonin) and the neurotrophic factor BDNF likely contribute to the disease process. Abnormal accumulations of neurotoxic forms of amyloid β-peptide, tau and α-synuclein occur in brain regions involved in the regulation of sleep in AD and PD patients, and are sufficient to cause sleep disturbances in animal models of these neurodegenerative disorders. Disturbed regulation of sleep often occurs early in the course of AD and PD, and may contribute to the cognitive and motor symptoms. Treatments that target signaling pathways that control sleep have been shown to retard the disease process in animal models of AD and PD, suggesting a potential for such interventions in humans at risk for or in the early stages of these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Adlard, P. A., Perreau, V. M., Pop, V., & Cotman, C. W. (2005). Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. Journal of Neuroscience, 25, 4217–4221.

    Article  PubMed  CAS  Google Scholar 

  • Ahlskog, J. E. (2011). Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology, 77, 288–294.

    Article  PubMed  Google Scholar 

  • Andretic, R., van Swinderen, B., & Greenspan, R. J. (2005). Dopaminergic modulation of arousal in Drosophila. Current Biology, 15, 1165–1175.

    Article  PubMed  CAS  Google Scholar 

  • Arumugam, T. V., Phillips, T. M., Cheng, A., Morrell, C. H., Mattson, M. P., & Wan, R. (2010). Age and energy intake interact to modify cell stress pathways and stroke outcome. Annals of Neurology, 67, 41–52.

    Article  PubMed  CAS  Google Scholar 

  • Baddeley, A. D., Baddeley, H. A., Bucks, R. S., & Wilcock, G. K. (2001). Attentional control in Alzheimer’s disease. Brain, 124, 1492–1508.

    Article  PubMed  CAS  Google Scholar 

  • Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., et al. (2010). Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer’s disease. Journal of Alzheimer’s Disease, 22, 569–579.

    PubMed  CAS  Google Scholar 

  • Barraud, Q., Lambrecq, V., Forni, C., McGuire, S., Hill, M., Bioulac, B., et al. (2009). Sleep disorders in Parkinson’s disease: The contribution of the MPTP non-human primate model. Experimental Neurology, 2, 574–582.

    Article  CAS  Google Scholar 

  • Bedrosian, T. A., Herring, K. L., Weil, Z. M., & Nelson, R. J. (2011). Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice. Proceedings of the National Academy of Sciences of the USA, 108, 11686–11691.

    Article  PubMed  CAS  Google Scholar 

  • Berkowitz, A., Sutton, L., Janowsky, D. S., & Gillin, J. C. (1990). Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers. Psychiatry Research, 33, 113–119.

    Article  PubMed  CAS  Google Scholar 

  • Bliwise, D. L., Tinklenberg, J., Yesavage, J. A., Davies, H., Pursley, A. M., Petta, D. E., et al. (1989). REM latency in Alzheimer’s disease. Biol Psychiat., 25, 320–328.

    Article  PubMed  CAS  Google Scholar 

  • Boeve, B. F., Silber, M. H., Saper, C. B., Ferman, T. J., Dickson, D. W., Parisi, J. E., et al. (2007). Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain, 130, 2770–2788.

    Article  PubMed  CAS  Google Scholar 

  • Boldrini, M., Underwood, M. D., Hen, R., Rosoklija, G. B., Dwork, A. J., John Mann, J., et al. (2009). Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology, 34, 2376–2389.

    Article  PubMed  CAS  Google Scholar 

  • Braak, H., Del Tredici, K., Rüb, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24, 197–211.

    Article  PubMed  Google Scholar 

  • Brown, S. A., Schmitt, K., & Eckert, A. (2011). Aging and circadian disruption: Causes and effects. Aging, 3, 813–817.

    PubMed  Google Scholar 

  • Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983). A primate model of parkinsonism—selective destruction of dopaminergic-neurons in the pars compacta of the substantia nigra by n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. PNAS, 80, 4546–4550.

    Article  PubMed  CAS  Google Scholar 

  • Cai, J. X., & Arnsten, A. F. T. (1997). Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. Journal of Pharmacology and Experimental Therapeutics, 283, 183–189.

    PubMed  CAS  Google Scholar 

  • Chen, M. J., & Russo-Neustadt, A. A. (2007). Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent. Growth Factors, 25, 118–131.

    Article  PubMed  CAS  Google Scholar 

  • Chow, T. W., Pollock, B. G., & Milgram, N. W. (2007). Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease. Journal of Neuropsychiatric Disease and Treatment, 3, 627–636.

    CAS  Google Scholar 

  • Cirrito, J. R., Disabato, B. M., Restivo, J. L., Verges, D. K., Goebel, W. D., Sathyan, A., et al. (2011). Serotonin signaling is associated with lower amyloid-{beta} levels and plaques in transgenic mice and humans. Proceedings of the National Academy of Sciences of the USA, 108, 14968–14973.

    Article  PubMed  CAS  Google Scholar 

  • Claassen, D. O., Josephs, K. A., Ahlskog, J. E., Silber, M. H., Tippmann-Peikert, M., & Boeve, B. F. (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology, 75, 494–499.

    Article  PubMed  CAS  Google Scholar 

  • Comella, C. L. (2003). Sleep disturbances in Parkinson’s disease. Current Neurology and Neuroscienece Reports, 2, 173–180.

    Article  Google Scholar 

  • Comella, C. L. (2007). Sleep disorders in Parkinson’s disease: An overview. Movement Disorders, 17, S367–S373.

    Article  Google Scholar 

  • Craig, D., Hart, D. J., & Passmore, A. P. (2006). Genetically increased risk of sleep disruption in Alzheimer’s disease. Sleep, 29, 1003–1007.

    PubMed  Google Scholar 

  • Crowley, K. (2011). Sleep and sleep disorders in older adults. Neuropsychology Review, 21, 41–53.

    Article  PubMed  Google Scholar 

  • Dahan, L., Astier, B., Vautrelle, N., Urbain, N., Kocsis, B., & Chouvet, G. (2007). Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology, 32, 1232–1241.

    Article  PubMed  CAS  Google Scholar 

  • Dauvilliers, Y. (2007). Insomnia in patients with neurodegenerative conditions. Sleep Medicine, 4, S27–S34.

    Article  Google Scholar 

  • Dong, H., Goico, B., Martin, M., Csernansky, C. A., Bertchume, A., & Csernansky, J. G. (2004). Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience, 127, 601–609.

    Article  PubMed  CAS  Google Scholar 

  • Duan, W., & Mattson, M. P. (1999). Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. Journal of Neuroscience Research, 57, 195–206.

    Article  PubMed  CAS  Google Scholar 

  • Eisensehr, I., Linke, R., Noachtar, S., Schwarz, J., Gildehaus, F. J., & Tatsch, K. (2000). Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson’s disease and controls. Brain, 123, 1155–1160.

    Article  PubMed  Google Scholar 

  • Factor, S. A., McAlarney, T., Sanchez-Ramos, J. R., & Weiner, W. J. (1990). Sleep disorders and sleep effect in Parkinson’s disease. Movement Disorders, 5, 280–285.

    Article  PubMed  CAS  Google Scholar 

  • Feng, Z., Qin, C., Chang, Y., & Zhang, J. T. (2006). Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer’s disease. Free Radical Biology & Medicine, 40, 101–109.

    Article  CAS  Google Scholar 

  • Franzen, P. L., & Buysse, D. J. (2008). Sleep disturbances and depression: Risk relationships for subsequent depression and therapeutic implications. Dialogues in Clinical Neuroscience, 10, 473–481.

    PubMed  Google Scholar 

  • Friedman, L. F., Zeitzer, J. M., Lin, L., Hoff, D., Mignot, E., Peskind, E. R., et al. (2007). In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1. Neurology, 68, 793–794.

    Article  PubMed  CAS  Google Scholar 

  • Fronczek, R., Overeem, S., Lee, S. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., et al. (2007). Hypocretin (orexin) loss in Parkinson’s disease. Brain, 130, 1577–1585.

    Article  PubMed  Google Scholar 

  • Fronczek, R., van Geest, S., Frölich, M., Overeem, S., Roelandse, F. W., Lammers, G. J. et al. (2011) Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiological Aging (Epub).

  • Gagnon, J. F., Bédard, M. A., Fantini, M. L., Petit, D., Panisset, M., Rompré, S., et al. (2002). REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology, 59, 585–589.

    Article  PubMed  CAS  Google Scholar 

  • Gaig, C., & Tolosa, E. (2009). When does Parkinson’s disease begin? Movement Disorders, 24(Suppl 2), S656–S664.

    Article  PubMed  Google Scholar 

  • German, D. C., Yazdani, U., Speciale, S. G., Pasbakhsh, P., Games, D., & Liang, C. L. (2003). Cholinergic neuropathology in a mouse model of Alzheimer’s disease. The Journal of Comparative Neurology, 462, 371–381.

    Article  PubMed  Google Scholar 

  • Giacobini, E. (2003). Cholinergic function and Alzheimer’s disease. International Journal of Geriatric Psychiatry, 18, S1–S5.

    Article  PubMed  Google Scholar 

  • Gingrich, J. A. (2002). Mutational analysis of the serotonergic system: Recent findings using knockout mice. Current Drug Targets: CNS & Neurological Disorders, 1, 449–465.

    Article  CAS  Google Scholar 

  • Grinberg, L. T., Rueb, U., Alho, A. T., & Heinsen, H. (2010). Brainstem pathology and non-motor symptoms in PD. Journal of the Neurological Sciences, 289, 81–88.

    Article  PubMed  Google Scholar 

  • Grothe, M., Heinsen, H., & Teipel, S. J. (2011) Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer’s Disease. Biological Psychiatry (Epub).

  • Halagappa, V. K., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R. G., Laferla, F. M., et al. (2007). Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer’s disease. Neurobiology of Diseases, 26, 212–220.

    Article  CAS  Google Scholar 

  • Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011). Melatonin—a pleiotropic, orchestrating regulator molecule. Progress in Neurobiology, 93, 350–384.

    Article  PubMed  CAS  Google Scholar 

  • Harkany, T., O’Mahony, S., Keijser, J., Kelly, J. P., Kónya, C., Borostyánkoi, Z. A., et al. (2001). Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiology of Diseases, 8, 667–678.

    Article  CAS  Google Scholar 

  • Harkany, T., Penke, B., & Luiten, P. G. (2000). beta-Amyloid excitotoxicity in rat magnocellular nucleus basalis. Effect of cortical deafferentation on cerebral blood flow regulation and implications for Alzheimer’s disease. Annals of the New York Academy of Sciences, 903, 374–386.

    Article  PubMed  CAS  Google Scholar 

  • Harley, C. (1991). Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Progress in Brain Research, 88, 307–321.

    Article  PubMed  CAS  Google Scholar 

  • Heneka, M. T., Galea, E., Gavriluyk, V., Dumitrescu-Ozimek, L., Daeschner, J., O’Banion, M. K., et al. (2002). Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: Implications for Alzheimer’s disease. Journal of Neuroscience, 22, 2434–2442.

    PubMed  CAS  Google Scholar 

  • Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., & Javoy-Agid, F. (1987). Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. PNAS, 84, 5976–5980.

    Article  PubMed  CAS  Google Scholar 

  • Hobson, J. A., & Pace-Schott, E. F. (2002). The cognitive neuroscience of sleep: Neuronal systems, consciousness and learning. Nature Reviews Neuroscience, 3, 679–693.

    Article  PubMed  CAS  Google Scholar 

  • Insua, D., Suárez, M. L., Santamarina, G., Sarasa, M., & Pesini, P. (2010). Dogs with canine counterpart of Alzheimer’s disease lose noradrenergic neurons. Neurobiology of Aging, 31, 625–635.

    Article  PubMed  CAS  Google Scholar 

  • Irvine, G. B., El-Agnaf, O. M., Shankar, G. M., & Walsh, D. M. (2008). Protein aggregation in the brain: The molecular basis for Alzheimer’s and Parkinson’s diseases. Molecular Medicine, 14, 451–464.

    Article  PubMed  CAS  Google Scholar 

  • Isaac, S. O., & Berridge, C. W. (2003). Wake-promoting actions of dopamine D1 and D2 receptor stimulation. Journal of Pharmacology and Experimental Therapeutics, 307, 386–394.

    Article  PubMed  CAS  Google Scholar 

  • Kalinin, S., Gavrilyuk, V., Polak, P. E., Vasser, R., Zhao, J., Heneka, M. T., et al. (2007). Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer’s disease. Neurobiology of Aging, 28, 1206–1214.

    Article  PubMed  CAS  Google Scholar 

  • Kang, J. E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science, 326, 1005–1007.

    Article  PubMed  CAS  Google Scholar 

  • Kim, E. J., Lee, B. H., Seo, S. W., Moon, S. Y., Jung, D. S., Park, K. H., et al. (2007). Attentional distractibility by optokinetic stimulation in Alzheimer disease. Neurology, 69, 1105–1112.

    Article  PubMed  CAS  Google Scholar 

  • Kremer, H. P., & Bots, G. T. (1993). Lewy bodies in the lateral hypothalamus: Do they imply neuronal loss? Movement Disorders, 8, 315–320.

    Article  PubMed  CAS  Google Scholar 

  • Kroeger, D., & de Lecea, L. (2009). The hypocretins and their role in narcolepsy. CNS & Neurological Disorders: Drug Targets, 8, 271–280.

    Article  CAS  Google Scholar 

  • Kudo, T., Loh, D. H., Truong, D., Wu, Y., Colwell, C. S. (2011) Circadian dysfunction in a mouse model of Parkinson’s disease. Experimental Neurology. (Epub).

  • Laloux, C., Derambure, P., Houdayer, E., Jacquesson, J. M., Bordet, R., Destée, A., et al. (2008). Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice. Journal of Sleep Research, 17, 101–110.

    Article  PubMed  Google Scholar 

  • Lange-Asschenfeldt, C., & Kojda, G. (2008). Alzheimer’s disease, cerebrovascular dysfunction and the benefits of exercise: From vessels to neurons. Experimental Gerontology, 43, 499–504.

    Article  PubMed  CAS  Google Scholar 

  • Lau, Y. S., Patki, G., Das-Panja, K., Le, W. D., & Ahmad, S. O. (2011). Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration. European Journal of Neuroscience, 33, 1264–1274.

    Article  PubMed  Google Scholar 

  • Lees, A. J., Blackburn, N. A., & Campbell, V. L. (1988). The nighttime problems of Parkinson’s disease. Clinical Neuropharmacology, 11, 512–519.

    Article  PubMed  CAS  Google Scholar 

  • Léna, I., Parrot, S., Deschaux, O., Muffat-Joly, S., Sauvinet, V., Renaud, B., et al. (2005). Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep–wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. Journal of Neuroscience Research, 81, 891–899.

    Article  PubMed  CAS  Google Scholar 

  • Lessig, S., Ubhi, K., Galasko, D., Adame, A., Pham, E., Remidios, K., et al. (2010). Reduced hypocretin (orexin) levels in dementia with Lewy bodies. NeuroReport, 21, 756–760.

    Article  PubMed  Google Scholar 

  • Lima, M. M., Andersen, M. L., Reksidler, A. B., Vital, M. A., & Tufik, S. (2007). The role of the substantia nigra pars compacta in regulating sleep patterns in rats. PLoS ONE, 2, e513.

    Article  PubMed  CAS  Google Scholar 

  • Luchsinger, J. A., Tang, M. X., Shea, S., & Mayeux, R. (2002). Caloric intake and the risk of Alzheimer disease. Archives of Neurology, 59, 1258–1263.

    Article  PubMed  Google Scholar 

  • Maloney, K. J., Mainville, L., & Jones, B. E. (2002). c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery. European Journal of Neuroscience, 15, 774–778.

    Article  PubMed  Google Scholar 

  • Maria, B., Sophia, S., Michalis, M., Charalampos, L., Andreas, P., John, M. E., et al. (2003). Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respiratory Medicine, 10, 1151–1157.

    Article  Google Scholar 

  • Martin, B., Ji, S., Maudsley, S., & Mattson, M. P. (2010). “Control” laboratory rodents are metabolically morbid: Why it matters. Proceedings of the National Academy of Sciences of the USA, 107, 6127–6133.

    Article  PubMed  CAS  Google Scholar 

  • Maswood, N., Young, J., Tilmont, E., Zhang, Z., Gash, D. M., Gerhardt, G. A., et al. (2004). Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease. Proceedings of the National Academy of Sciences of the USA, 101, 18171–18176.

    Article  PubMed  CAS  Google Scholar 

  • Matsubara, E., Bryant-Thomas, T., Pacheco Quinto, J., Henry, T. L., Poeggeler, B., Herbert, D., et al. (2003). Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. Journal of Neurochemistry, 85, 1101–1108.

    Article  PubMed  CAS  Google Scholar 

  • Mattson, M. P., Maudsley, S., & Martin, B. (2004). BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences, 27, 589–594.

    Article  PubMed  CAS  Google Scholar 

  • McCurry, S. M., Logsdon, R. G., Teri, L., Gibbons, L. E., Kukull, W. A., Bowen, J. D., et al. (1999). Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. Journal of Geriatric Psychiatry and Neurology, 12, 53–59.

    Article  PubMed  CAS  Google Scholar 

  • McDowell, K. A., Hadjimarkou, M. M., Viechweg, S., Rose, A. E., Clark, S. M., Yarowsky, P. J., et al. (2010). Sleep alterations in an environmental neurotoxin-induced model of parkinsonism. Experimental Neurology, 226, 84–89.

    Article  PubMed  CAS  Google Scholar 

  • McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E., & Nagai, T. (1984). Aging, Alzheimer’s disease, and the cholinergic system of the basal forebrain. Neurology, 34, 741–745.

    Article  PubMed  CAS  Google Scholar 

  • McMorris, T., Harris, R. C., Swain, J., Corbett, J., Collard, K., Dyson, R. J., et al. (2006). Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl), 185, 93–103.

    Article  CAS  Google Scholar 

  • Michelsen, K. A., Prickaerts, J., & Steinbusch, H. W. (2008). The dorsal raphe nucleus and serotonin: Implications for neuroplasticity linked to major depression and Alzheimer’s disease. Progress in Brain Research, 172, 233–264.

    Article  PubMed  CAS  Google Scholar 

  • Mishima, K., Tozawa, T., Satoh, K., Matsumoto, Y., Hishikawa, Y., & Okawa, M. (1999). Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biological Psychiatry, 45, 417–421.

    Article  PubMed  CAS  Google Scholar 

  • Mitra, T., & Chaudhuri, K. R. (2009). Sleep dysfunction and role of dysautonomia in Parkinson’s disease. Parkinsonism and Related Disorders, 15, S93–S95.

    Article  PubMed  Google Scholar 

  • Miyamoto, T., Miyamoto, M., Inoue, Y., Usui, Y., Suzuki, K., & Hirata, K. (2006). Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology, 67, 2236–2238.

    Article  PubMed  CAS  Google Scholar 

  • Monte-Silva, K., Kuo, M. F., Thirugnanasambandam, N., Liebetanz, D., Paulus, W., & Nitsche, M. A. (2009). Dose-dependent inverted U-shaped effect of dopamine (D2-Like) receptor activation on focal and nonfocal plasticity in humans. Journal of Neuroscience, 29, 6124–6131.

    Article  PubMed  CAS  Google Scholar 

  • Monti, J. M., & Monti, D. (2007). The involvement of dopamine in the modulation of sleep and waking. Sleep Medicine Reviews, 11, 113–133.

    Article  PubMed  Google Scholar 

  • Moore, R. Y. (1993). Principles of synaptic transmission. Annals of the New York Academy of Sciences, 695, 1–9.

    Article  PubMed  CAS  Google Scholar 

  • Moraes Wdos, S., Poyares, D. R., Guilleminault, C., Ramos, L. R., Bertolucci, P. H., & Tufik, S. (2006). The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: A double-blind placebo-controlled study. Sleep, 29, 199–205.

    PubMed  Google Scholar 

  • Moran, M., Lynch, C. A., Walsh, C., Coen, R., Coakley, D., & Lawlor, B. A. (2005). Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Medicine, 6, 347–352.

    Article  PubMed  Google Scholar 

  • Muijsers, R. B., Plosker, G. L., & Noble, S. (2002). Sertraline: A review of its use in the management of major depressive disorder in elderly patients. Drugs and Aging, 19, 377–392.

    Article  PubMed  CAS  Google Scholar 

  • Myhrer, T. (2003). Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks. Brain Research Reviews, 41, 268–287.

    Article  PubMed  CAS  Google Scholar 

  • Naidoo, N., Zhu, J., Zhu, Y., Fenik, P., Lian, J., Galante, R., et al. (2011). Endoplasmic reticulum stress in wake-active neurons progresses with aging. Aging Cell, 10, 640–649.

    Article  PubMed  CAS  Google Scholar 

  • Nelson, R. L., Guo, Z., Halagappa, V. M., Pearson, M., Gray, A. J., Matsuoka, Y., et al. (2007). Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Experimental Neurology, 205, 166–176.

    Article  PubMed  CAS  Google Scholar 

  • Niu, S. F., Chung, M. H., Chen, C. H., Hegney, D., O’Brien, A., & Chou, K. R. (2011). The effect of shift rotation on employee cortisol profile, sleep quality, fatigue, and attention level: A systematic review. Journal of Nursing Research, 19, 68–81.

    Article  PubMed  Google Scholar 

  • Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., et al. (2009). Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Journal of Pineal Research, 47, 82–96.

    Article  PubMed  CAS  Google Scholar 

  • Pace-Schott, E. F., & Hobson, J. A. (2002). The neurobiology of sleep: Genetics, cellular physiology and subcortical networks. Nature Reviews Neuroscience, 3, 591–605.

    PubMed  CAS  Google Scholar 

  • Palmer, A. M., & DeKosky, S. T. (1993). Monoamine neurons in aging and Alzheimer’s disease. Journal of Neural Transmission. General Section, 91, 135–159.

    Article  PubMed  CAS  Google Scholar 

  • Parachikova, A., Nichol, K. E., & Cotman, C. W. (2008). Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiology of Diseases, 30, 121–129.

    Article  CAS  Google Scholar 

  • Postuma, R. B., Gagnon, J. F., Vendette, M., & Montplaisir, J. Y. (2009). Idiopathic REM sleep behavior disorder in the transition to degenerative disease. Movement Disorders, 24, 2225–2232.

    Article  PubMed  Google Scholar 

  • Postuma, R. B., Lanfranchi, P. A., Blais, H., Gagnon, J. F., & Montplaisir, J. Y. (2010). Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Movement Disorders, 25, 2304–2310.

    Article  PubMed  Google Scholar 

  • Powers, R. E., Struble, R. G., Casanova, M. F., O’Connor, D. T., Kitt, C. A., & Price, D. L. (1988). Innervation of human hippocampus by noradrenergic systems: Normal anatomy and structural abnormalities in aging and in Alzheimer’s disease. Neuroscience, 25, 401–417.

    Article  PubMed  CAS  Google Scholar 

  • Pungor, K., Papp, M., Kékesi, K., & Juhász, G. (1990). A novel effect of MPTP: The selective suppression of paradoxical sleep in cats. Brain Research, 525, 310–314.

    Article  PubMed  CAS  Google Scholar 

  • Qu, W. M., Xu, X. H., Yan, M. M., Wang, Y. Q., Urade, Y., & Huang, Z. L. (2010). Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. Journal of Neuroscience, 30, 4382–4389.

    Article  PubMed  CAS  Google Scholar 

  • Riederer, P., Bartl, J., Laux, G., & Grünblatt, E. (2011). Diabetes type II: A risk factor for depression-Parkinson-Alzheimer? Neurotoxicity Research, 19, 253–265.

    Article  PubMed  Google Scholar 

  • Robbins, T. W. (1997). Arousal systems and attentional processes. Biological Psychology, 45, 57–71.

    Article  PubMed  CAS  Google Scholar 

  • Romberg, C., Mattson, M. P., Mughal, M. R., Bussey, T. J., & Saksida, L. M. (2011). Impaired attention in the 3xTgAD mouse model of Alzheimer’s disease: Rescue by donepezil (Aricept). Journal of Neuroscience, 31, 3500–3507.

    Article  PubMed  CAS  Google Scholar 

  • Santos, R. V., Tufik, S., & De Mello, M. T. (2007). Exercise, sleep and cytokines: Is there a relation? Sleep Medicine Reviews, 11, 231–239.

    Article  PubMed  CAS  Google Scholar 

  • Sarkar, S., Katshu, M. Z., Nizamie, S. H., & Praharaj, S. K. (2010). Slow wave sleep deficits as a trait marker in patients with schizophrenia. Schizophrenia Research, 124, 127–133.

    Article  PubMed  Google Scholar 

  • Saunders, N. L., & Summers, M. J. (2010). Attention and working memory deficits in mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology, 32, 350–357.

    Article  PubMed  Google Scholar 

  • Schenck, C. H., & Mahowald, M. W. (2003). REM behavior disorder (RBD): Delayed emergence of parkinsonism and/or dementia in 65 % of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum and maximum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep, 26, A316Abs.

    Google Scholar 

  • Seamans, J. K., & Yang, C. R. (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in Neurobiology, 74, 1–58.

    Article  PubMed  CAS  Google Scholar 

  • Sherrill, D. L., Kotchou, K., & Quan, S. F. (1998). Association of physical activity and human sleep disorders. Archives of Internal Medicine, 158, 1894–1898.

    Article  PubMed  CAS  Google Scholar 

  • Siderowf, A., & Jennings, D. (2010). Cardiac denervation in rapid eye movement sleep behavior disorder and Parkinson’s disease: Getting to the heart of the matter. Movement Disorders, 25, 2269–2271.

    Article  PubMed  Google Scholar 

  • Skene, D. J., & Swaab, D. F. (2003). Melatonin rhythmicity: Effect of age and Alzheimer’s disease. Experimental Gerontology, 38, 199–206.

    Article  PubMed  CAS  Google Scholar 

  • Sterniczuk, R., Antle, M. C., Laferla, F. M., & Dyck, R. H. (2010). Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: Part 2. Behavioral and cognitive changes. Brain Research, 1348, 149–155.

    Article  PubMed  CAS  Google Scholar 

  • Stranahan, A. M., Lee, K., Martin, B., Maudsley, S., Golden, E., Cutler, R. G., et al. (2009). Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus, 19, 951–961.

    Article  PubMed  CAS  Google Scholar 

  • Tandberg, E., Larsen, J. P., & Karlsen, K. A. (1998). Community-based study of sleep disorders in patients with Parkinson’s disease. Movement Disorders, 13, 895–899.

    Article  PubMed  CAS  Google Scholar 

  • Tasali, E., Leproult, R., & Spiegel, K. (2009). Reduced sleep duration or quality: Relationships with insulin resistance and type 2 diabetes. Progress in Cardiovascular Diseases, 51, 381–391.

    Article  PubMed  CAS  Google Scholar 

  • Taylor, T. N., Caudle, W. M., Shepherd, K. R., Noorian, A., Jackson, C. R., Iuvone, P. M., et al. (2009). Nonmotor symptoms of Parkinson’s disease revealed in an animal model with reduced monoamine storage capacity. Journal of Neuroscience, 29, 8103–8113.

    Article  PubMed  CAS  Google Scholar 

  • Thal, D. R., Del Tredici, K., & Braak, H. (2004). Neurodegeneration in normal brain aging and disease. Science of Aging Knowledge Environment, 23, pe26.

    Article  Google Scholar 

  • Thannickal, T. C., Lai, Y. Y., & Siegel, J. M. (2007). Hypocretin (orexin) cell loss in Parkinson’s disease. Brain, 130, 1586–1595.

    Article  PubMed  Google Scholar 

  • Tsunematsu, T., Kilduff, T. S., Boyden, E. S., Takahashi, S., Tominaga, M., & Yamanaka, A. (2011). Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. Journal of Neuroscience, 31, 10529–10539.

    Article  PubMed  CAS  Google Scholar 

  • Tucker, S., Ahl, M., Cho, H. H., Bandyopadhyay, S., Cuny, G. D., Bush, A. I., et al. (2006). RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine. Current Alzheimer Research, 3, 221–227.

    Article  PubMed  CAS  Google Scholar 

  • Turner, R. S. (2002). Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies. Journal of Geriatric Psychiatry and Neurology, 15, 195–199.

    PubMed  Google Scholar 

  • van Someren, E. J., Hagebeuk, E. E., Lijzenga, C., Scheltens, P., de Rooij, S. E., Jonker, C., et al. (1996). Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biological Psychiatry, 40, 259–270.

    Article  PubMed  Google Scholar 

  • Verhave, P. S., Jongsma, M. J., Van den Berg, R. M., Vis, J. C., Vanwersch, R. A., Smit, A. B., et al. (2011). REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease. Sleep, 34, 1119–1125.

    PubMed  Google Scholar 

  • Vitiello, M. V., Prinz, P. N., Williams, D. E., Frommlet, M. S., & Ries, R. K. (1990). Sleep disturbances in patients with mild-stage Alzheimer’s disease. The Journals of Gerontology, 45, M131–M138.

    CAS  Google Scholar 

  • Volicer, L., Harper, D. G., Manning, B. C., Goldstein, R., & Satlin, A. (2001). Sundowning and circadian rhythms in Alzheimer’s disease. American Journal of Psychiatry, 158, 704–711.

    Article  PubMed  CAS  Google Scholar 

  • Walker, L. C., Levine, H., 3rd, Mattson, M. P., & Jucker, M. (2006). Inducible proteopathies. Trends in Neurosciences, 29, 438–443.

    Article  PubMed  CAS  Google Scholar 

  • Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., et al. (2005). Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer’s disease. FASEB Journal., 19, 659–661.

    Article  PubMed  CAS  Google Scholar 

  • Weinshenker, D. (2008). Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Current Alzheimer Research, 5, 342–345.

    Article  PubMed  CAS  Google Scholar 

  • Wisor, J. P., Edgar, D. M., Yesavage, J., Ryan, H. S., McCormick, C. M., Lapustea, N., et al. (2005). Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: A role for cholinergic transmission. Neuroscience, 131, 375–385.

    Article  PubMed  CAS  Google Scholar 

  • Wu, Y. H., Zhou, J. N., Van Heerikhuize, J., Jockers, R., & Swaab, D. F. (2007). Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease. Neurobiology of Aging, 28, 1239–1247.

    Article  PubMed  CAS  Google Scholar 

  • Yanovsky, Y., Li, S., Klyuch, B. P., Yao, Q., Blandina, P., Passani, M. B., et al. (2011). L-Dopa activates histaminergic neurons. Journal of Physiology, 589, 1349–1366.

    Article  PubMed  CAS  Google Scholar 

  • Zant, J. C., Leenaars, C. H., Kostin, A., Van Someren, E. J., & Porkka-Heiskanen, T. (2011). Increases in extracellular serotonin and dopamine metabolite levels in the basal forebrain during sleep deprivation. Brain Research, 1399, 40–48.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, B., Veasey, S. C., Wood, M. A., Leng, L. Z., Kaminski, C., Leight, S., et al. (2005). Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer’s disease with injury to pedunculopontine cholinergic neurons. American Journal of Pathology, 167, 1361–1369.

    Article  PubMed  CAS  Google Scholar 

  • Zigmond, M. J., Cameron, J. L., Leak, R. K., Mirnics, K., Russell, V. A., Smeyne, R. J., et al. (2009). Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism & Related Disorders, 15(Suppl 3), S42–S45.

    Article  Google Scholar 

Download references

Acknowledgment

This research was supported entirely by the Intramural Research Program of the NIH, National Institute on Aging.

Author information

Authors and Affiliations

  1. Laboratory of Neurosciences, National Institute On Aging Intramural Research Program, Baltimore, MD, 21224, USA

    Sarah M. Rothman & Mark P. Mattson

Authors
  1. Sarah M. Rothman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark P. Mattson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah M. Rothman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rothman, S.M., Mattson, M.P. Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases. Neuromol Med 14, 194–204 (2012). https://doi.org/10.1007/s12017-012-8181-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-012-8181-2

Keywords

Search

Navigation